e-Drug3D

1729

BELINOSTAT


INN
BELINOSTAT

cas 414864-00-9
CLASS

ANTINEOPLASTIC
HISTONE DEACETYLASE (HDAC) INHIBITOR
TREATMENT OF T-CELL LYMPHOMA (PTCL)

ROUTE (list)

INTRAVENOUS

ATC code

L01XH04

PK parameters

VD 40 LITER
Cl 74.4 LITER / HOUR
PPB 94.3 PERCENT
t1/2 1.1 HOUR

Solubility

SLIGHTLY SOLUBLE IN DISTILLED WATER (0.14 MILLIGRAM / MILLILITER)


Target

TARGET HISTONE DEACETYLASE (HDAC)

PDB
5EEN (CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 IN COMPLEX WITH BELINOSTAT)

Ligand code = 5OG (link to the list of PDB complexes)

Download experimental 3D coordinates of 5OG with added hydrogens

DrugCentral

Histone deacetylase 5 UNIPROT Q9UQL6 HDAC5

Histone deacetylase 2 UNIPROT Q92769 HDAC2

Download SDF file 2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-

Formula:
C15H14N2O4S

Calculated chemical properties:

MW 318.35
NB_atoms 22
XLogP 2.01
PSA 99.313
NB_HD 3
NB_HA 6
fsp3 0.00
Lipinski(0=no;1=yes) 1

FDA
NDA 206256 (pdf not found) INN (BELINOSTAT) BELEODAQ (ACROTECH BIOPHARMA) APPROVAL= AP YEAR= 2014 NEWMOLECULARENTITY

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL